Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
CCR10+ epithelial cells from idiopathic pulmonary fibrosis lungs drive remodeling
David M. Habiel, … , Barry Stripp, Cory M. Hogaboam
David M. Habiel, … , Barry Stripp, Cory M. Hogaboam
Published August 23, 2018
Citation Information: JCI Insight. 2018;3(16):e122211. https://doi.org/10.1172/jci.insight.122211.
View: Text | PDF
Research Article Cell biology Pulmonology

CCR10+ epithelial cells from idiopathic pulmonary fibrosis lungs drive remodeling

  • Text
  • PDF
Abstract

Idiopathic pulmonary fibrosis (IPF) is a devastating fibrotic lung disease of unknown etiology and limited therapeutic options. In this report, we characterize what we believe is a novel CCR10+ epithelial cell population in IPF lungs. There was a significant increase in the percentage of CCR10+ epithelial cells in IPF relative to normal lung explants and their numbers significantly correlated to lung remodeling in humanized NSG mice. Cultured CCR10-enriched IPF epithelial cells promoted IPF lung fibroblast invasion and collagen 1 secretion. Single-cell RNA sequencing analysis showed distinct CCR10+ epithelial cell populations enriched for inflammatory and profibrotic transcripts. Consistently, cultured IPF but not normal epithelial cells induced lung remodeling in humanized NSG mice, where the number of CCR10+ IPF, but not normal, epithelial cells correlated with hydroxyproline concentration in the remodeled NSG lungs. A subset of IPF CCR10hi epithelial cells coexpress EphA3 and ephrin A signaling induces the expression of CCR10 by these cells. Finally, EphA3+CCR10hi epithelial cells induce more consistent lung remodeling in NSG mice relative to EphA3–CCR10lo epithelial cells. Our results suggest that targeting epithelial cells, highly expressing CCR10, may be beneficial in IPF.

Authors

David M. Habiel, Milena S. Espindola, Isabelle C. Jones, Ana Lucia Coelho, Barry Stripp, Cory M. Hogaboam

×

Figure 1

EpCAM+CCR10+ epithelial cells are abundant in IPF lung explants and their numbers correlated to lung remodeling in humanized NSG mice.

Options: View larger image (or click on image) Download as PowerPoint
EpCAM+CCR10+ epithelial cells are abundant in IPF lung explants and thei...
(A–C) Normal, COPD, and IPF lung explant cellular suspensions were stained with fluorescently conjugated anti-CD45, anti-EpCAM, and anti-CCR10 antibodies and analyzed by flow cytometry. Shown are representative dot plots from normal (left, n = 10), COPD (middle, n = 3), and IPF (right, n = 12) lung explants depicting CD45–EpCAM+ (A), CD45–EpCAM+CCR10+ (B) and CD45–EpCAM–CCR10+ (C) cells. (D–F) Shown is the percentage of CD45–EpCAM+ (D), CCR10+ cells within CD45–EpCAM+ (E) and CD45–EpCAM– (F) cells in normal, COPD, and IPF lung explants. Data shown are the mean ± SEM. *P ≤ 0.05; ***P ≤ 0.001; ****P ≤ 0.0001 via 1-way ANOVA corrected with Dunnett’s test. NSG-GFP or NSG mice were intravenously administered with IPF lung explant cells; 35 days after cellular administration, lung cellular suspensions were analyzed by flow cytometry and hydroxyproline concentration was quantified from lung homogenates. (G) Depicted is the mean number of GFP–EpCAM+CCR10+ cells in the lungs of naive and IPF humanized NSG-GFP mice. Data shown are the mean ± SEM. *P ≤ 0.05 via unpaired Mann-Whitney 2-tailed nonparametric test. (H) Depicted is a correlation analyses of hydroxyproline concentration and number of human CD45–EpCAM+CCR10+ cells in IgG-treated NSG lungs after 35 days of IPF cell administration. n = 4–5/group. P values indicated. IPF, idiopathic pulmonary fibrosis; NSG, NOD Cg-PrkdcSCID IL2rgTm1wilSzi; NSG-GFP, NOD.Cg-PrkdcSCID IL2rgtm1Wil Tg (CAG-EGFP) 10sb/SzJ.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts